• Skip to content
  • Skip to primary sidebar
  • Home
  • About

Radio America Online News Bureau

drugs

Elon Musk & Twitter, Biden Nixing ‘Remain in Mexico’ Policy, Kamala’s Voter ID Nonsense

April 4, 2022 by GregC

Listen to “Elon Musk & Twitter, Biden Nixing 'Remain in Mexico' Policy, Kamala's Voter ID Nonsense” on Spreaker.
Join Greg and Rob Long as they’re glad to see Elon Musk becoming the largest shareholder of Twitter and they analyze how it will shake up the social media landscape. They also cover the Biden Administration’s decision to rescind the “Remain in Mexico” policy which would more than double the number of illegal immigrants entering America each month. And Vice President Kamala Harris struggles with boilerplate Democrat talking points in an interview with BET, adding to the lengthy list of verbal mishaps that have plagued her term.

Please visit our great sponsors:

Moink
https://moinkbox.com/martini
Get your FREE year of filet mignon when you sign up today!

My Pillow
https://www.mypillow.com/martini
Use code MARTINI for the 6-piece My Pillow Towel set for $39.99. SAVE $70!

Share

Filed Under: Big Tech, Border Security, congress, Constitution, COVID-19, Cyber Terrorism, Economy, Education, Elections, Energy, History, Humor, Immigration, Inflation, law, Military, News & Politics, Podcasts, polls, Privacy, Social Media, Space, Supply Chain Tagged With: 3MartiniLunch, 42, Biden, border, California, capitalism, censorship, democrats, demographics, drugs, Elon, illegals, immigration, Kamala, Kelly, space, stocks, Trump, Twitter, wall

A Plan to Re-Open, More Promising Treatments, Oprah’s Iffy Doctors

April 17, 2020 by GregC

Listen to “A Plan to Re-Open, More Promising Treatments, Oprah’s Iffy Doctors” on Spreaker.

Join Jim and Greg for an upbeat Friday edition!  Today, after assessing Joe Biden’s latest live television mess, they welcome the three-phase plan to bring the U.S. economy back to life. They also marvel at the medicinal and practical ways our hospitals are treating COVID-19. And they break down the curious arguments of Dr. Phil and Dr. Oz, both of whom became household names courtesy of Oprah.

Share

Filed Under: Economy, Health Care, Journalism, News & Politics Tagged With: COVID-19, Dr. Oz, Dr. Phil, drugs, Economy, Joe Biden, National Review, Oprah, Three Martini Lunch, treatment

Unemployment Skyrockets, U.S Indicts Maduro, COVID-19 Terrorism Threat

March 26, 2020 by GregC

Listen to “Unemployment Skyrockets, U.S Indicts Maduro, COVID-19 Terrorism Threat” on Spreaker.

Jim and Greg shudder as 3.28 million Americans lost their jobs last week. They also recoil at an alleged plot to bomb a hospital full of COVID-19 patients. But they cheer the U.S. lowering the boom on Venezuelan dictator Nicholas Maduro.

This episode is sponsored by Acre Gold. Go to getacregold.com/martini. Acre is giving away a gold bar for the month of March. Tweet why you should win and mention @get_acre for a chance to win the free gold.

Share

Filed Under: congress, Crime, Economy, Foreign Policy, Health Care, News & Politics Tagged With: COVID-19, drugs, Economy, Maduro, National Review, Terrorism, Three Martini Lunch, unemployment, Venezuela

How to Protect Our Prescription Drug Supply Chain

March 25, 2020 by GregC

Listen to “How to Protect Our Prescription Drug Supply Chain” on Spreaker.

There’s no crisis of prescription drug availability right now as the COVID-19 crisis unfolds, but as supply chains suffer some disruptions and China threatens to withhold medications produced there by U.S. pharmaceuticals, how can we make sure there’s never a problem?

Former FDA Associate Commissioner Peter Pitts says there is a way to induce much more domestic production of prescription drugs. In this interview with Greg Corombos, Pitts explains what the federal government would need to do to give drug makers the incentive to move production back home and the major infrastructure investment pharmaceuticals would need to make.

But Pitts also points out that domestic production is more expensive, so how does the tension between price and availability of drugs play out?

Pitts walks us through these key issues and explains the role of the FDA during the current crisis and what it ought to be doing once it is over.

Share

Filed Under: Podcasts Tagged With: China, COVID-19, drugs, FDA, news, production

Greatness of the Free Market, China’s Ugly Threat, Pelosi’s Partisan Ploy

March 13, 2020 by GregC

Listen to “Greatness of the Free Market, China’s Ugly Threat, Pelosi’s Partisan Ploy” on Spreaker.

As Jim says, this week has been a very long year.  But it is Friday, and while so much is closed, the Three Martini Lunch is open!  Join Jim and Greg as they praise the innovation in the private sector (and at universities) to produce new coronavirus tests that are accurate, can be produced in mass quantities, and can deliver results much more quickly.  They also love the entrepreneurial instinct in a British teenager who sold his classmates squirts of hand sanitizer.  They also unload on communist China for brazen lies like the U.S. military launched the coronavirus in China and for threatening to cut off supplies of much needed medications to the U.S. at our time of need.  And they hammer House Speaker Nancy Pelosi for trying to cram a billion dollars for taxpayer-funded abortions into the coronavirus relief legislation.

Share

Filed Under: Abortion, congress, Economy, Foreign Policy, Health Care, News & Politics, Podcasts, Sports Tagged With: abortion, China, coronavirus, drugs, entrepreneur, Nancy Pelosi, National Review, tests, Three Martini Lunch

Mayor Pete Faces the Heat, China Charged with Equifax Hack, Biden’s Nonstop Blunders

February 10, 2020 by GregC

Listen to “Mayor Pete Faces the Heat, China Charged with Equifax Hack, Biden’s Nonstop Blunders” on Spreaker.

Prepare for another busy political week by starting with Monday’s Three Martini Lunch. Join Jim and Greg as they enjoy watching Pete Buttigieg flail for an answer after ABC’s Linsey Davis calls him out for black people being four times more likely to be arrested for marijuana possession than whites while Buttigieg was mayor of South Bend. They also hammer the Chinese government after the Justice Department indicts four Chinese military figures for the 2017 Equifax hack that compromised the information of more than 145 million people. And they react to more bizarre statements from Joe Biden over this past weekend and wonder whether his campaign is just stumbling right now or whether it’s on the brink of imploding.

Share

Filed Under: congress, Economy, Foreign Policy, Journalism, News & Politics, Podcasts Tagged With: 2020, China, coronavirus, democrats, drugs, Equifax, hack, Joe Biden, Linsey Davis, National Review, Pete Buttigieg, race, Three Martini Lunch

Tories Crush Corbyn, Tentative Trade Optimism, Biden’s Big Problem

December 13, 2019 by GregC

Listen to “Tories Crush Corbyn, Tentative Trade Optimism, Biden’s Big Problem” on Spreaker.

It’s finally Friday!  Yes, we are fully aware of the impeachment votes in the House Judiciary Committee but Jim sums up his analysis in roughly two seconds as we begin today’s podcast.  After that Jim and Greg celebrate the big win for the Conservative Party in the UK and are thrilled to report the political demise of Jeremy Corbyn.  They are also hoping that the substance matches the excitement as Congress prepares to pass the U.S.-Mexico-Canada trade agreement to replace NAFTA and President Trump announces agreement on “phase one” of trade negotiations with China.  And Jim details why Joe Biden’s campaign could face serious turbulence after reports that Hunter Biden had a 1988 drug arrest expunged at the same time Sen. Biden was advocating for very tough drug crime sentencing.

Share

Filed Under: News & Politics, Podcasts Tagged With: Boris Johnson, Brexit, China, drugs, Hunter Biden, Jeremy Corbyn, Joe Biden, National Review, parliament, President Trump, trade, UK, USMCA

Cost of Prescription Drugs: Price vs. Progress

November 11, 2019 by GregC

Listen to “Cost of Prescription Drugs: Price vs. Progress” on Spreaker.

Democrats in Congress are pushing legislation to force pharmaceuticals to lower the cost of prescription drugs.  The goal is to ensure that all Americans can afford the medicines they need to preserve their health.

Pharmaceutical companies are pushing back, stressing that researching and developing successful new medicines costs billions of dollars, and the unsuccessful efforts cost a lot of money too.  They say prescription drug prices cannot be artificially lowered or else efforts to bring new and better treatments to market will be derailed.

How exactly would the legislation from Democrats work?  Why are prescription drug prices so much lower in other countries than they are in the U.S.?  What can be done to help patients afford the drugs they need right now without stalling progress on future treatments?

We tackle all of these questions and more with Chris Jacobs, CEO of the Juniper Research Group and author of “The Case Against Single-Payer.”

Share

Filed Under: Podcasts Tagged With: costs, development, drugs, news, prescription, treatments

Florida Sheriff’s Deputy Accused of Framing Innocent People

July 12, 2019 by GregC

Listen to “Florida Sheriff’s Deputy Accused of Framing Innocent People” on Spreaker.

A former Jackson County, Florida, sheriff’s deputy is facing 52 felony charges in connection with allegedly planting drugs on motorists he pulled over.

According to the charges and released body cam footage, Zach Wester allegedly framed a minimum of 10 people, some of whom were involved in court-ordered recovery programs. One victim even lost custody of his daughter because of Wester’s corrupt actions.

How did Wester plant drugs in people’s cars? How was he caught? How did authorities respond to the allegations? What constitutional protections did most of the victims forget to invoke?

Reason.com reporter C.J. Ciaramella chronicled this horrible case on Wednesday. He joins Greg Corombos for a closer look at the details and whether there is evidence of this becoming a bigger problem in the U.S.

Share

Filed Under: News & Politics, Podcasts Tagged With: deputy, drugs, Florida, news, planting

Trump Strategies to Lower Drug Prices: One Smart, One Not

February 1, 2019 by GregC

Listen to “Trump Strategies to Lower Drug Prices: One Smart, One Not” on Spreaker.

President Trump is trying to make good on a campaign promise to ease the financial burden Americans face when paying for prescription drugs, but a leading policy expert says one Trump strategy is right on target while another could lead to disaster.

Americans pay the highest prices in the world for prescription drugs by a wide margin, and American Commitment President Phil Kerpen says it’s because other nations are taking advantage of us.

“Pretty much all of the other rich countries have some form of government price controls.  So they set prices far lower what a market-clearing price would be through government policy,” said Kerpen, who says American pharmaceutical companies do not have the option of not dealing with those other nations.

“If you try to do that, the other country will typically just try to steal your patent and have a local company produce it without compensating you or compensating you even lower,” said Kerpen.

As a result, the Trump administration is pressuring developed nations to ease price controls on prescription medications through trade negotiations.  Kerpen says Canada and Mexico are already on board with paying higher costs through the new trade deal that will soon replace the North American Free Trade Agreement.

Kerpen believes trade negotiations are the best way to address the problem and says the best argument for raising costs abroad is that the additional revenue will lead to more effective treatments for many ailments.

“If the other rich countries gave up their price controls, two things would happen.  We would get a lot more new cures developed because we’d get a lot more research and development.  There would be a lot more incentive to invest in it.

“The best research shows we’d get 10-13 new drugs per year if they loosen price controls in the other rich countries, but we’d also get lower prices in the U.S. through more competition,” said Kerpen.

The prices Americans pay for drugs provides the bulk of the funding for research and development.  Kerpen says bringing a new drug to market costs $2.5 billion to $3 billion when factoring in the cost of compliance with government regulations and all the resources spent on drug projects that fail.

While pushing hard on the trade side, Health and Human Services Secretary Alex Azar is exploring price controls here in the U.S.  Kerpen says Trump needs to abandon that effort or else innovation could be strangled.

“[It] feels good in the near term.  We’re paying less.  That seems good, but that would completely undermine the incentives for R&D in developing new cures.  Instead of the rest of the world free-riding on us.  There would be no one to free ride off of.  There would be no place to earn a market return.

Listen to the full podcast to hear Kerpen’s full diagnosis of the high prescription drug costs we face and why he says the Trump administration must abandon the domestic price controls if it hopes to win trade concessions from developed nations.

Share

Filed Under: News & Politics, Podcasts Tagged With: controls, drugs, news, prescription, Price, trade

  • Page 1
  • Page 2
  • Next Page »

Primary Sidebar

Recent

  • DeSantis Right on Crime, Western Water Woes, Flunking Constitution 101
  • Iowa Chooses School Choice, Adams’ Border Complaints, Schiff’s Senate Run
  • McCarthy Rejects Schiff & Swalwell, Santos Plays Victim, Pence’s Classified Papers
  • Afghanistan Accountability, U.S. Arsenal Vanishing, Lightfoot’s Crime ‘Solution’
  • Dems Target Sinema, Klain Leaving White House, Tank Fight

Archives

  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008

Copyright © 2023 · News Pro on Genesis Framework · WordPress · Log in